ICICI Prudential Nifty Pharma Index Fund: AUM ₹83 Cr, expense ratio 0.51%, 1Y return +12.79%. Track returns, risk and NAV history.
| Fund House (AMC) | ICICI Prudential Mutual Fund |
|---|---|
| Category | Other Scheme - Index Funds |
| Scheme Code | 150930 |
| ISIN | INF109KC11M9 |
| AUM | ₹83 Cr |
| Expense Ratio | 0.51% |
| Launch Date | 25-11-2022 (4.0 yrs) |
| 1-Year Return | +12.79% |
| 3-Year Return | +19.38% |
| Alpha (vs Nifty 50) | +18.61% |
| Standard Deviation | 13.88% |
| Sortino Ratio | 0.70 |
| Exit Load | Entry Load: Not Applicable Exit Load: Nil |
You can check the live AMFI NAV of ICICI Prudential Nifty Pharma Index Fund - Direct Plan - Growth (Scheme Code: 150930) on this page or in our Live Data scanner.
The expense ratio of ICICI Prudential Nifty Pharma Index Fund - Direct Plan - Growth is 0.51% per annum, deducted daily from the scheme's Net Asset Value (NAV).
ICICI Prudential Nifty Pharma Index Fund - Direct Plan - Growth manages Assets Under Management (AUM) of approximately ₹83 Cr and was launched on 25-11-2022.
Trailing annualized returns for ICICI Prudential Nifty Pharma Index Fund - Direct Plan - Growth are 1-Year: +12.79%, 3-Year: +19.38%. Past performance is not indicative of future results.
The AMFI scheme code for ICICI Prudential Nifty Pharma Index Fund - Direct Plan - Growth is 150930 and its ISIN is INF109KC11M9. It is managed by ICICI Prudential Mutual Fund.